Arkolith/Insider Trading/ERNA/Form 4/A

Cherington Charles

10% OwnerErnexa Therapeutics Inc. (ERNA) · full profile →Form 4/A · filed May 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
5 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 24, 2024Buy(P)1.6M——13.8M
Sep 24, 2024Buy(P)5.4M——12.2M
Sep 24, 2024Buy(P)1.2M——6.8M
Sep 24, 2024Buy(P)4.8M——5.6M
Sep 24, 2024Buy(P)262K——818K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 24, 2024Sell(S)2.5M——0
Sep 24, 2024Sell(S)524K——0
Sep 24, 2024Sell(S)0——0
Sep 24, 2024Sell(S)0——0
Sep 24, 2024Sell(S)3.1M——0

Transaction Codes

P
Open-market purchase
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-25-045416) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML